Seer (NASDAQ: SEER)
Seer Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Seer Company Info
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.
News & Analysis
Why Shares of Seer Are Slumping Wednesday
The company reported a net loss but improved revenue in the second quarter.
CEO of Newly IPO'd Seer: For Biotech Investors, Proteins Are The New DNA
Seer's CEO Dr. Omid Farokhzad describes the revolutionary potential in the proteomics sector and what investors should know.
Valuation
Earnings Transcripts
Seer, Inc. (SEER) Q2 2022 Earnings Call Transcript
SEER earnings call for the period ending June 30, 2022.
Seer, Inc. (SEER) Q1 2022 Earnings Call Transcript
SEER earnings call for the period ending March 31, 2022.
Seer, Inc. (SEER) Q4 2021 Earnings Call Transcript
SEER earnings call for the period ending December 31, 2021.
Seer, Inc. (SEER) Q3 2021 Earnings Call Transcript
SEER earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.